AU5308200A - 48 human secreted proteins - Google Patents
48 human secreted proteinsInfo
- Publication number
- AU5308200A AU5308200A AU53082/00A AU5308200A AU5308200A AU 5308200 A AU5308200 A AU 5308200A AU 53082/00 A AU53082/00 A AU 53082/00A AU 5308200 A AU5308200 A AU 5308200A AU 5308200 A AU5308200 A AU 5308200A
- Authority
- AU
- Australia
- Prior art keywords
- secreted proteins
- human secreted
- human
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13863199P | 1999-06-11 | 1999-06-11 | |
US60138631 | 1999-06-11 | ||
PCT/US2000/014963 WO2000077256A1 (en) | 1999-06-11 | 2000-06-01 | 48 human secreted proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5308200A true AU5308200A (en) | 2001-01-02 |
Family
ID=22482904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53082/00A Abandoned AU5308200A (en) | 1999-06-11 | 2000-06-01 | 48 human secreted proteins |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1192278A4 (en) |
JP (1) | JP2003502058A (en) |
AU (1) | AU5308200A (en) |
CA (1) | CA2382185A1 (en) |
WO (1) | WO2000077256A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541224B2 (en) | 1996-03-14 | 2003-04-01 | Human Genome Sciences, Inc. | Tumor necrosis factor delta polypeptides |
US7217788B2 (en) | 1996-03-14 | 2007-05-15 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta polypeptides |
US6689579B1 (en) | 1996-10-25 | 2004-02-10 | Human Genome Sciences, Inc. | Polynucleotides encoding neutrokine-α |
US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
US20030095967A1 (en) | 1999-01-25 | 2003-05-22 | Mackay Fabienne | BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders |
US7220840B2 (en) | 2000-06-16 | 2007-05-22 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
PT2281843T (en) * | 2000-06-16 | 2017-01-02 | Human Genome Sciences Inc | Antibodies that immunospecifically bind to blys |
US20030091565A1 (en) | 2000-08-18 | 2003-05-15 | Beltzer James P. | Binding polypeptides and methods based thereon |
WO2003000865A2 (en) * | 2001-03-27 | 2003-01-03 | Human Genome Sciences, Inc. | Human secreted proteins |
EP1401870A4 (en) | 2001-05-24 | 2006-04-19 | Human Genome Sciences | Antibodies against tumor necrosis factor delta (april) |
CA2446610A1 (en) * | 2001-06-06 | 2002-12-12 | Human Genome Sciences, Inc. | 20 human secreted proteins |
JPWO2003087364A1 (en) * | 2002-04-16 | 2005-08-18 | 田辺製薬株式会社 | Novel G protein-coupled receptor and gene thereof |
WO2004071379A2 (en) * | 2003-02-17 | 2004-08-26 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor p2y10 (p2y10) |
US9168286B2 (en) | 2005-10-13 | 2015-10-27 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive disease |
US8211649B2 (en) | 2006-03-31 | 2012-07-03 | Human Genome Sciences, Inc. | Methods of diagnosing and prognosing hodgkin's lymphoma |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07203998A (en) * | 1994-01-26 | 1995-08-08 | Hamamatsu Photonics Kk | Method for determining nucleic acid base sequence |
US5776746A (en) * | 1996-05-01 | 1998-07-07 | Genitope Corporation | Gene amplification methods |
US5994132A (en) * | 1996-10-23 | 1999-11-30 | University Of Michigan | Adenovirus vectors |
EP0977836A4 (en) * | 1997-02-21 | 2002-10-16 | Univ California | Leafy cotyledon1 genes and their uses |
WO1999018208A1 (en) * | 1997-10-02 | 1999-04-15 | Human Genome Sciences, Inc. | 101 human secreted proteins |
CA2291260A1 (en) * | 1997-06-06 | 1998-12-10 | Human Genome Sciences, Inc. | 207 human secreted proteins |
-
2000
- 2000-06-01 EP EP00937977A patent/EP1192278A4/en not_active Withdrawn
- 2000-06-01 AU AU53082/00A patent/AU5308200A/en not_active Abandoned
- 2000-06-01 JP JP2001503696A patent/JP2003502058A/en not_active Withdrawn
- 2000-06-01 CA CA002382185A patent/CA2382185A1/en not_active Abandoned
- 2000-06-01 WO PCT/US2000/014963 patent/WO2000077256A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000077256A1 (en) | 2000-12-21 |
EP1192278A4 (en) | 2003-05-28 |
EP1192278A1 (en) | 2002-04-03 |
CA2382185A1 (en) | 2000-12-21 |
JP2003502058A (en) | 2003-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1473501A (en) | 21 human secreted proteins | |
AU1604401A (en) | 18 human secreted proteins | |
AU1438001A (en) | 27 human secreted proteins | |
AU1334101A (en) | 19 human secreted proteins | |
AU5308200A (en) | 48 human secreted proteins | |
AU3769700A (en) | 45 human secreted proteins | |
AU2757500A (en) | 33 human secreted proteins | |
AU3517000A (en) | 50 human secreted proteins | |
AU1918601A (en) | 23 human secreted proteins | |
AU1916101A (en) | 19 human secreted proteins | |
AU3628600A (en) | 46 human secreted proteins | |
AU1342501A (en) | 32 human secreted proteins | |
AU3765500A (en) | 50 human secreted proteins | |
AU3396600A (en) | 49 human secreted proteins | |
AU3208700A (en) | 33 human secreted proteins | |
AU3249300A (en) | 47 human secreted proteins | |
AU1472801A (en) | 24 human secreted proteins | |
AU4072300A (en) | 50 human secreted proteins | |
AU3767300A (en) | 47 human secreted proteins | |
AU3766800A (en) | 48 human secreted proteins | |
AU3628700A (en) | 49 human secreted proteins | |
AU3871300A (en) | 50 human secreted proteins | |
AU1655701A (en) | 15 human secreted proteins | |
AU1438201A (en) | 25 human secreted proteins | |
AU3529000A (en) | 47 human secreted proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |